The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease.
about
Interventions for fatigue in Parkinson's diseaseSide effects of a dopamine agonist therapy for Parkinson's disease: a mini-review of clinical pharmacologyStriatal cholinergic interneuron regulation and circuit effectsAn overview of systematic reviews of shenmai injection for healthcareParkinsonian syndromesDrug-induced dyskinesia in Parkinson's disease. Should success in clinical management be a function of improvement of motor repertoire rather than amplitude of dyskinesia?Initial medication in patients of newly diagnosed Parkinson's disease in TaiwanPharmacotherapies for Parkinson's disease symptoms related to cholinergic degeneration.Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy studyDeep brain stimulation for movement disordersQuantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker.Efficacy of rasagiline in early Parkinson's disease: a meta-analysis of data from the TEMPO and ADAGIO studies.Timing of deep brain stimulation in Parkinson disease: a need for reappraisal?Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson's disease.Review: management of Parkinson's disease.Continuous drug delivery in Parkinson's disease.Nationwide Survey of Patient Knowledge and Attitudes towards Human Experimentation Using Stem Cells or Bee Venom Acupuncture for Parkinson's DiseaseNew treatments for the motor symptoms of Parkinson's disease.Therapeutic advances in multiple system atrophy and progressive supranuclear palsy.The safety and efficacy of safinamide mesylate for the treatment of Parkinson's disease.Effects of home exercise on physical function and activity in home care patients with Parkinson's disease.Comparison of strength training, aerobic training, and additional physical therapy as supplementary treatments for Parkinson's disease: pilot study.Five-year follow-up of 23 asymmetrical Parkinson's disease patients treated with unilateral subthalamic nucleus stimulation.Glutamatergic pathways as a target for the treatment of dyskinesias in Parkinson's disease.Monoamine reuptake inhibitors in Parkinson's disease.Asian perspectives on the recognition and management of levodopa 'wearing-off' in Parkinson's disease.Trends in inpatient antiparkinson drug use in the USA, 2001-2012.Update on deep brain stimulation in Parkinson's disease.Parkinson's Disease and Its Management: Part 3: Nondopaminergic and Nonpharmacological Treatment Options.Impulsivities and Parkinson's disease: delay aversion is not worsened by Deep Brain Stimulation of the subthalamic nucleus.Virtual reality for rehabilitation in Parkinson's disease.An updated meta-analysis of amantadine for treating dyskinesia in Parkinson's disease.Referring Parkinson's disease patients for deep brain stimulation: a RAND/UCLA appropriateness study.Cell based therapy in ParkinsonismPramipexole in patients with early Parkinson's disease (PROUD): a randomised delayed-start trial.Effect of Age and Disease Duration on the Levodopa Response in Patients with Advanced Parkinson's Disease for Deep Brain Stimulation of the Subthalamic Nucleus.Conversion to IPX066 from Standard Levodopa Formulations in Advanced Parkinson's Disease: Experience in Clinical Trials.Clinical Outcomes in Patients with Parkinson's Disease Treated with a Monoamine Oxidase Type-B inhibitor: A Cross-Sectional, Cohort StudyTherapeutic effects of tai chi in patients with Parkinson's disease.The KMDS-NATION Study: Korean Movement Disorders Society Multicenter Assessment of Non-Motor Symptoms and Quality of Life in Parkinson's Disease NATION Study Group
P2860
Q24186581-97693C26-5E55-4BCC-943C-48CBF18D19BCQ26738349-CF311567-F09E-4217-B4A8-21AA373F0B42Q26863113-AB5D2494-300F-459A-91D8-86A591C71A2CQ26997968-7A110656-F608-46AF-A1DF-740464AB6B9DQ27007524-688C78CF-60B4-4717-8ABE-CC675A1F0B6AQ27021464-173A1005-1698-463C-B069-6A8204B0F602Q28542989-A93E8687-3040-41E1-8596-0358D7E7D937Q30244035-786A9B57-0792-4ABF-8DF9-339B5B5ED8F3Q30366253-D2DA5916-30AC-423E-B8DD-AFF97D4FD6F8Q30585845-B8663E46-1572-4265-8C3F-15F5F64BD8DFQ30837513-31E5A6F9-F335-44C6-AA6D-44C66DB63D96Q31060186-12D918F7-1955-46C5-9F63-0B8B8AF681E7Q33785397-34BA6B5D-573D-484F-BBD4-E855E054485CQ33917311-D7DA1F45-093F-4738-BFAB-2F05AB36318CQ34332812-56FBAF46-25DD-43F5-A2C2-B0222920DB93Q34390800-7DE435A2-22C6-4007-8564-07554BDC04B3Q34423287-9B1FF176-8C9B-4E88-B1FA-D6DDB8D91485Q34443682-FE1B30C6-1CFB-4C47-8E73-1EA69475D7B0Q34487619-681B0E1C-8A27-4D02-A199-CAC367248F55Q34512544-0B7FDD61-3800-4246-B3D5-780581B31742Q34567180-01AF5103-B265-4E98-9281-16558AB72E9EQ34944530-E20F8A57-706C-4648-908E-97E78F83E232Q35020852-7FF84B59-281D-4F6E-B58C-F7B3B99A37E0Q35124773-383EB899-F925-4AA7-8CFB-CBB8125F9DDBQ35165280-43DF6507-6E1F-46EF-AA64-A31D40FA8200Q35781883-AB8BD97A-3F86-405C-8180-C9BA9AE9E42EQ35847512-3361897D-43D9-4D22-B7D8-D090564BE004Q35930039-337CCF0B-0793-4152-AA11-216B69D8158FQ36164724-859E693F-FBC8-4940-BDE5-EAAC0FD5AED9Q36226872-E0F6AA5E-0FDB-4989-9DF6-6F8EB827E05BQ36230160-DC5BF804-5564-4C55-89DD-640C34C49308Q36376607-CE94E87B-11B9-4B96-BB06-79E1042CC53FQ36492253-0A2D42A0-CC4E-401E-A28E-BB3AD50A4063Q36908657-04A961F9-D158-4976-9340-5AFFCA0EFCF6Q37022421-252245F9-1E7D-48BB-9F87-F7E1C816260EQ37039109-5ED37CEF-175E-4CA2-9D50-30F16978FC93Q37054013-F8B66C38-374E-4064-A2A5-45F607DB5F77Q37279146-6C8DA162-9FD1-4EA8-B43A-242E52F54775Q37323339-DE74EE13-AB6D-4A20-A222-9F26C751952AQ37338662-554D8B50-FBAB-4ACF-99FC-0D4635CEBB18
P2860
The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The Movement Disorder Society ...... mptoms of Parkinson's disease.
@en
The Movement Disorder Society ...... mptoms of Parkinson's disease.
@nl
type
label
The Movement Disorder Society ...... mptoms of Parkinson's disease.
@en
The Movement Disorder Society ...... mptoms of Parkinson's disease.
@nl
prefLabel
The Movement Disorder Society ...... mptoms of Parkinson's disease.
@en
The Movement Disorder Society ...... mptoms of Parkinson's disease.
@nl
P2093
P2860
P50
P356
P1433
P1476
The Movement Disorder Society ...... mptoms of Parkinson's disease.
@en
P2093
Bernard Ravina
Miguel Coelho
Shen-Yang Lim
P2860
P356
10.1002/MDS.23829
P407
P478
26 Suppl 3
P50
P577
2011-10-01T00:00:00Z